Back to top

Image: Bigstock

Why Delek US Holdings (DK) Stock Might be a Great Pick

Read MoreHide Full Article

One stock that might be an intriguing choice for investors right now is Delek US Holdings, Inc. (DK - Free Report) . This is because this security in the Oils-Energy space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Oils-Energy space as it currently has a Zacks Industry Rank of 51 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Delek US Holdings is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

Delek US Holdings, Inc. Price and Consensus

In fact, over the past month, current quarter estimates have increased from 28 cents per share to 33 cents per share while current year estimates have also risen from 68 cents per share to 86 cents per share. The company currently carries a Zacks Rank #1 (Strong Buy), which is a favorable signal. You can see the complete list of today’s Zacks #1 Rank stocks here.

So, if you are looking for a decent pick in a strong industry, consider Delek US Holdings. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Delek US Holdings, Inc. (DK) - free report >>

Published in